Red Cell Alloimmunization and Autoimmunization in Multi-Transfused Thalassemia Patients in Sulaymaniyah Province-Iraq
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Thalassemias are considered important health issues throughout Iraq, involving its Kurdistan region. This disorder, particularly its major form, needs lifelong regular transfusions. But this form of medical care is associated with various complications including red cell alloimmunization and autoim-munization. This study determined the frequency and associations of alloimmunization among multi-transfused patients with β-thalassemia major. The subjects were 204 patients who were registered at a thalassemia care center in Sulaymaniyah-Iraqi Kurdistan. The patients’ records were analyzed, their red cells were phenotyped for ABO/RhD antigens using the gel card method, and irregular antibody screening/identification was performed using the standard tube method. Alloantibodies were detected in 5.8% of the patients, while DAT was positive in 4% of the patients, which indicated autoantibodies. The identified alloantibodies were anti-E (2.4%), anti-C (1.4%), anti-e (1%), and anti-K (1%). A patient’s age at the start of transfusion (＞2 years) (P=0.042) and a positive history of transfusion reactions (P=0.003) were correlated with a significantly higher rate of alloantibody formation. From the results of our study, we conclude that measures to decrease the development of alloantibodies may incorporate matching for Rhesus and Kell systems and early induction of blood transfusions.
Abstract
Thalassemias are considered important health issues throughout Iraq, involving its Kurdistan region. This disorder, particularly its major form, needs lifelong regular transfusions. But this form of medical care is associated with various complications including red cell alloimmunization and autoim-munization. This study determined the frequency and associations of alloimmunization among multi-transfused patients with β-thalassemia major. The subjects were 204 patients who were registered at a thalassemia care center in Sulaymaniyah-Iraqi Kurdistan. The patients’ records were analyzed, their red cells were phenotyped for ABO/RhD antigens using the gel card method, and irregular antibody screening/identification was performed using the standard tube method. Alloantibodies were detected in 5.8% of the patients, while DAT was positive in 4% of the patients, which indicated autoantibodies. The identified alloantibodies were anti-E (2.4%), anti-C (1.4%), anti-e (1%), and anti-K (1%). A patient’s age at the start of transfusion (＞2 years) (P=0.042) and a positive history of transfusion reactions (P=0.003) were correlated with a significantly higher rate of alloantibody formation. From the results of our study, we conclude that measures to decrease the development of alloantibodies may incorporate matching for Rhesus and Kell systems and early induction of blood transfusions.
참고문헌 (28)
- DAVID J. WEATHERALL, "The Molecular Basis for Phenotypic Diversity of Genetic Disease", Annals of the New York Academy of Sciences, 758(1 DNA), pp.245~260 (1995), Wiley[DOI]
- Iheanyi EO, "Practical management of haemoglobinopathies" (2004), Blackwell publishing
- Hanan A. Hamamy, "Epidemiological profile of common haemoglobinopathies in Arab countries", Journal of Community Genetics, 4(2), pp.147~167 (2013), Springer Science and Business Media LLC[DOI]
- Anchalee Thedsawad, "Prevalence and clinical significances of red cell alloimmunization and red cell bound immunoglobulin G in polytransfused patients with thalassemias", Hematology, 24(1), pp.208~214 (2019), Informa UK Limited[DOI]
- Cappellini MD, "Guidelines for the management of transfusion dependent thalassaemia (TDT)" (2014), Thalassaemia International Federation
- Azza Mohamed Ahmed, "Red cell alloimmunization and autoantibodies in Egyptian transfusion-dependent thalassaemia patients", Archives of Medical Science, 4, pp.592~598 (2010), Termedia Sp. z.o.o.[DOI]
- Singer ST, "Alloimmunization and erythrocyte autoimmunization in transfusion-dependent thalassemia patients of predominantly Asian descent", Blood, 96, pp.3369~3373 (2000)
- Eiman Hussein, "Predictors of Red Cell Alloimmunization in Multitransfused Egyptian Patients With β-Thalassemia", Archives of Pathology & Laboratory Medicine, 138(5), pp.684~688 (2014), Archives of Pathology and Laboratory Medicine[DOI]
- CN Chaudhari, "Red Cell Alloantibodies in Multiple Transfused Thalassaemia Patients", Medical Journal Armed Forces India, 67(1), pp.34~37 (2011), Elsevier BV[DOI]
- Reem Ameen, "RBC alloimmunization and autoimmunization among transfusion-dependent Arab thalassemia patients", Transfusion, 43(11), pp.1604~1610 (2003), Wiley[DOI]
- Sangeeta Pahuja, "Alloimmunization and red cell autoimmunization in multitransfused thalassemics of Indian origin", Hematology, 15(3), pp.174~177 (2013), Informa UK Limited[DOI]
- L.-Y. Wang, "Alloimmunization among patients with transfusion-dependent thalassemia in Taiwan", Transfusion Medicine, 16(3), pp.200~203 (2006), Wiley[DOI]
- M.A.S. Salama, "Erythrocyte autoantibodies and expression of CD59 on the surface of red blood cells of polytransfused patients with ß-thalassaemia major", British Journal of Biomedical Science, 61(2), pp.88~92 (2018), Informa UK Limited[DOI]
- Shamsian BS, "Frequency of red cell alloimmunization in patients with β-major thalassemia in an Iranian referral hospital", Iran J Pediatr, 18, pp.149~153 (2008)
- HariKrishan Dhawan, "Alloimmunization and autoimmunization in transfusion dependent thalassemia major patients: Study on 319 patients", Asian Journal of Transfusion Science, 8(2), pp.84~88 (2014), Medknow[DOI]
- Pampee P. Young, "Autoantibody formation after alloimmunization: are blood tranfusions a risk factor for autoimmune hemolytic anemia?", Transfusion, 44(1), pp.67~72 (2004), Wiley[DOI]
- Deepak Singhal, "Red cell alloimmunization is associated with development of autoantibodies and increased red cell transfusion requirements in myelodysplastic syndrome", Haematologica, 102(12), pp.2021~2029 (2017), Ferrata Storti Foundation (Haematologica)[DOI]
- Hisham AG, "Distribution of red cell antigens according to ABO, Rh and other rare blood group systems in Kurdish ethnicity", Iraqi J Hematology, 5, pp.55~80 (2016)[DOI]
- Roback JD, "Technical manual" (2008), AABB
- Stella T. Chou, "Challenges of alloimmunization in patients with haemoglobinopathies", British Journal of Haematology, 159(4), pp.394~404 (2012), Wiley[DOI]
- Muqdad M.N. Al-Mousawi, "Predictors of Red Cell Alloimmunization in Kurdish Multi Transfused Patients with Hemoglobinopathies in Iraq", Hemoglobin, 39(6), pp.423~426 (2015), Informa UK Limited[DOI]
- Alexis A. Thompson, "Red cell alloimmunization in a diverse population of transfused patients with thalassaemia", British Journal of Haematology, 153(1), pp.121~128 (2011), Wiley[DOI]
- Jamil M.A.S. Obaid, "Red blood cells alloimmunization and autoimmunization among transfusion-dependent beta-thalassemia patients in Alexandria province, Egypt", Transfusion and Apheresis Science, 53(1), pp.52~57 (2015), Elsevier BV[DOI]
- Dalia A. Saied, "Alloimmunization and Erythrocyte Autoimmunization in Transfusion-dependent Egyptian Thalassemic Patients", Journal of Pediatric Hematology, 2011, pp.33(6), 409~414[DOI]
- Abeer Mohamed Abdelrazik, "Study of red blood cell alloimmunization risk factors in multiply transfused thalassemia patients: role in improving thalassemia transfusion practice in Fayoum, Egypt", Transfusion, 56(9), pp.2303~2307 (2016), Wiley[DOI]
- Jeengar RK, "Red cell alloimmunization in repeatedly transfused children with beta thalassemia major", Int J Contemp Pediatr, 4, pp.775~779 (2017)[DOI]
- Ansuman Sahu, "Detection of red cell alloantibodies in thalassaemia patients", International Journal of Contemporary Pediatrics, 7(2), pp.419~423 (2020), Medip Academy[DOI]
- Chao YH, "Red blood cell alloimmunization among Chinese patients with b-thalassaemia major in Taiwan", Blood Transfus, 11, pp.71~74 (2013)[DOI]